MGAT4A
Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A
Also known as: GnT-4a, GnT-Iva, MGT4A_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UM21
- Gene
- MGAT4A
- Ensembl
- ENSG00000071073
- Chromosome
- 2
- Canonical length
- 535 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins
- Subcellular location
- Golgi apparatus
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene encodes a key glycosyltransferase that regulates the formation of tri- and multiantennary branching structures in the Golgi apparatus. The encoded protein, in addition to the related isoenzyme B, catalyzes the transfer of N-acetylglucosamine (GlcNAc) from UDP-GlcNAc in a beta-1,4 linkage to the Man-alpha-1,3-Man-beta-1,4-GlcNAc arm of R-Man-alpha-1,6(GlcNAc-beta-1,2-Man-alpha-1,3)Man-beta-1,4-GlcNAc-beta-1,4-GlcNAc-beta-1-Asn. The encoded protein may play a role in regulating the availability of serum glycoproteins, oncogenesis, and differentiation. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
535 residues, UniProt reviewed canonical sequence.
>Q9UM21|MGAT4A
1 MRLRNGTVAT ALAFITSFLT LSWYTTWQNG KEKLIAYQRE FLALKERLRI AEHRISQRSS
61 ELNTIVQQFK RVGAETNGSK DALNKFSDNT LKLLKELTSK KSLQVPSIYY HLPHLLKNEG
121 SLQPAVQIGN GRTGVSIVMG IPTVKREVKS YLIETLHSLI DNLYPEEKLD CVIVVFIGET
181 DIDYVHGVVA NLEKEFSKEI SSGLVEVISP PESYYPDLTN LKETFGDSKE RVRWRTKQNL
241 DYCFLMMYAQ EKGIYYIQLE DDIIVKQNYF NTIKNFALQL SSEEWMILEF SQLGFIGKMF
301 QAPDLTLIVE FIFMFYKEKP IDWLLDHILW VKVCNPEKDA KHCDRQKANL RIRFRPSLFQ
361 HVGLHSSLSG KIQKLTDKDY MKPLLLKIHV NPPAEVSTSL KVYQGHTLEK TYMGEDFFWA
421 ITPIAGDYIL FKFDKPVNVE SYLFHSGNQE HPGDILLNTT VEVLPFKSEG LEISKETKDK
481 RLEDGYFRIG KFENGVAEGM VDPSLNPISA FRLSVIQNSA VWAILNEIHI KKATNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MGAT4A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 91 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 91 nTPM
- small intestine: 41 nTPM
- pancreas: 37 nTPM
- duodenum: 28 nTPM
- parathyroid gland: 26 nTPM
- kidney: 26 nTPM
Single-cell type
- microglia: 851 nCPM
- neutrophil progenitors: 259 nCPM
- t-cells: 237 nCPM
- macrophages: 194 nCPM
- enterocytes: 188 nCPM
- innate lymphoid cells: 156 nCPM
Immune cell
- naive CD4 T-cell: 33 nTPM
- MAIT T-cell: 28 nTPM
- naive CD8 T-cell: 27 nTPM
- memory CD4 T-cell: 25 nTPM
- memory CD8 T-cell: 24 nTPM
- gdT-cell: 21 nTPM
Brain region
- cerebellum: 52 nTPM
- white matter: 46 nTPM
- spinal cord: 37 nTPM
- basal ganglia: 35 nTPM
- medulla oblongata: 33 nTPM
- midbrain: 32 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.64
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.5
- DepMap mean gene effect
- -0.14
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- glycoprotein biosynthetic process
- glyoxylate metabolic process
- N-glycan processing
- protein N-linked glycosylation
- viral protein processing
Molecular functions
- acetylglucosaminyltransferase activity
- alanine-glyoxylate transaminase activity
- alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity
- metal ion binding
- protein homodimerization activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MGAT4A as an antibody target. Whether an autoantibody or antibody against MGAT4A could matter depends on whether native MGAT4A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MGAT4A is annotated as secreted, so native MGAT4A circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label MGAT4A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...